Member access

4-Traders Homepage  >  Shares  >  Xetra  >  Bayer AG    BAYN   DE000BAY0017

BAYER AG (BAYN)

311
SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsSector news 

Bayer Stops Sale of Glucose Meter Business

01/09/2013 | 06:07am US/Eastern

By Hendrik Varnholt

FRANKFURT--German pharmaceutical company Bayer AG (>> Bayer AG) will retain its blood glucose meter business, a spokeswoman said Wednesday, confirming a Bloomberg report.

Bayer had put up the unit for sale and had been in talks with French peer Sanofi SA (>> SANOFI) about a deal which could have been valued at around $1.5 billion, people familiar with the matter told Dow Jones Newswires in December.

"We have evaluated several options and decided to retain it," Bayer HealthCare chief Joerg Reinhardt said about the glucose meter business, according to Bloomberg.

Natali Schwab, Eyk Henning and Dana Cimilluca contributed to this story.

Write to Hendrik Varnholt at hendrik.varnholt@dowjones.com

Subscribe to WSJ: http://online.wsj.com?mod=djnwires

Stocks mentioned in the article : Bayer AG, SANOFI
React to this article
Latest news on BAYER AG
05/28 BAYER AG : ex-dividend day for annual dividend
05/27 BAYER : Aktiengesellschaft: Publication according to § 26 paragraph. 1 WpHG wit..
05/27 BAYER : CropScience at the ISF World Seed Congress 2015 in Kraków: -- Proactive ..
05/27 BAYER BAYER : has outstanding perspectives as a pure Life Science company -- Ver..
05/27 BAYER : Annual Stockholders’ Meeting -- Address by Dr. Marijn Dekkers -- C..
05/26DJEU to Revisit Question of Insecticides' Responsibility for Bee Die-Offs
05/26 BAYER : Boosts Foreign Direct Investment in Nigeria, Opens Lagos Office
05/23 BAYER : Aktiengesellschaft: Publication according to § 26 paragraph. 1 WpHG wit..
05/21DJFor CVS, Big Bet On Pricey Medicines
05/21DJCVS to Buy Omnicare for $10.4 Billion
Advertisement
Chart
Duration : Period :
Bayer AG Technical Analysis Chart | BAYN | DE000BAY0017 | 4-Traders
Income Statement Evolution
More Financials